(0.95%) 5 066.17 points
(0.92%) 38 251 points
(1.50%) 15 840 points
(0.22%) $79.17
(5.85%) $2.05
(0.23%) $2 316.30
(0.71%) $26.94
(1.15%) $965.85
(-0.11%) $0.932
(-0.39%) $10.99
(-0.11%) $0.798
(-1.40%) $91.96
-1.11% $ 54.55
@ $42.09
Wydano: 14 vas. 2024 @ 21:09
Zwrot: 29.60%
Poprzedni sygnał: vas. 14 - 17:24
Poprzedni sygnał:
Zwrot: -4.89 %
Live Chart Being Loaded With Signals
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance...
Stats | |
---|---|
Dzisiejszy wolumen | 115 779 |
Średni wolumen | 209 088 |
Kapitalizacja rynkowa | 933.23M |
EPS | $0 ( 2024-03-05 ) |
Następna data zysków | ( $-2.01 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.92 |
ATR14 | $0.0710 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-12 | Mastrocola Lauren | Sell | 48 | Common Stock |
2024-02-12 | Nemiroff Alex | Sell | 51 | Common Stock |
2024-02-12 | Souza Marcio | Sell | 271 | Common Stock |
2024-01-12 | Kelly Timothy Edwin | Buy | 30 000 | Stock Option (Right to Buy) |
2024-01-12 | Souza Marcio | Buy | 100 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
98.10 |
Last 99 transactions |
Buy: 3 195 196 | Sell: 875 304 |
Wolumen Korelacja
Praxis Precision Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
EUSG | 0.899 |
AAWW | 0.893 |
VICR | 0.884 |
CVCY | 0.865 |
CASH | 0.861 |
BPRN | 0.859 |
PXLW | 0.848 |
SMSI | 0.842 |
IMAB | 0.839 |
CIZN | 0.837 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Praxis Precision Korelacja - Waluta/Towar
Praxis Precision Finanse
Annual | 2023 |
Przychody: | $2.45M |
Zysk brutto: | $2.02M (82.35 %) |
EPS: | $-18.69 |
FY | 2023 |
Przychody: | $2.45M |
Zysk brutto: | $2.02M (82.35 %) |
EPS: | $-18.69 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.17M (0.00 %) |
EPS: | $-69.33 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.74 |
Financial Reports:
No articles found.
Praxis Precision
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej